世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

除去技術市場:製品毎(無線周波数、超音波、レーザ、凍結治療、マイクロ波)、用途毎(心循環系、がん、疼痛管理、美容外科) - 2021年までの世界市場予測

Ablation Technologies Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2017年2月US$5,650
シングルユーザライセンス
198 119

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の除去技術市場に関する調査レポートです。

The global ablation technologies market is expected to reach USD 4.73 billion by 2021 at a CAGR of 10.9% from 2016 to 2021. The growth of the market is driven by factors such as the increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, and the emergence of next-generation ablation products and technologies. However, product recalls and therapeutic challenges of the ablation devices are problems faced by market players in the market. Increasing funding for the development of novel ablation devices and emerging markets such as China, India, and Mexico are creating opportunities for the players involved in the market.

In this report, the market has been segmented on the basis of product (light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators), type (light/laser, radiofrequency, electrical, ultrasound, microwave, cryoablation, and hydrothermal), application (cancer, cardiovascular, gynecological, ophthalmological, urological, orthopedic, pain management, and cosmetic surgery), and region (North America, Europe, APAC, and the RoW).

The radiofrequency ablators market is estimated to account for the largest share of the market in 2016, followed by the light/laser ablators market. Use of RF ablators in primary interventional therapy for the treatment of many cardiac arrhythmias is a key factor driving the segment. Better temperature control by RF ablators as compared to other ablation products (such as electrical and microwave ablators) and clinical advantages offered by temperature-controlled RF ablators over traditional ablation approaches are further supporting the growth of this segment.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the market in 2016, followed by Europe. The market in North America is primarily driven by various factors including the presence of a large number of ablation product manufacturers, a significant rate of adoption of ablation treatment, large patient population base, and continuously rising prevalence of chronic disorders such as cancer and heart diseases (especially atrial fibrillation).

The market consists of a number of big, medium-sized, and small companies. In 2015, the market was dominated by Medtronic, plc (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.). Product launches, mergers & acquisitions, geographical expansions, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the market.

Research Coverage

This report studies the ablation technologies market based on type, product, and application. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles-which together discuss basic views on the competitive landscape, emerging and high-growth segments of the ablation technologies market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on products and services offered by major players in the ablation technologies market. The report analyzes the market based on type, product, application, and region

- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the ablation technologies market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation technologies products across geographies

- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the ablation technologies market

- Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the ablation technologies market



目次

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.4 MARKETS COVERED 19
1.4.1 YEARS CONSIDERED FOR THE STUDY 21
1.5 CURRENCY 21
1.6 LIMITATIONS 21
1.7 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH METHODOLOGY STEPS 22
2.2 RESEARCH DESIGN 23
2.3 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 23
2.3.1 SECONDARY RESEARCH 23
2.3.1.1 Key data from secondary sources 24
2.3.2 PRIMARY RESEARCH 25
2.3.2.1 Key data from primary sources 26
2.3.3 MARKET SIZE ESTIMATION METHODOLOGY 26
2.4 OPPORTUNITY INDICATORS 28
2.4.1 DEMAND-SIDE ANALYSIS 28
2.4.1.1 Incidence and prevalence of cancer 28
2.4.1.2 Rapid growth of geriatric population 29
2.4.1.3 Significant number of clinical researches in ablation 30
2.4.2 SUPPLY-SIDE ANALYSIS 31
2.4.2.1 Clinical trials by ablation technologies 32
2.4.2.2 Number of new product launches: ablation market (2013-2016) 32
2.5 MARKET DATA VALIDATION AND TRIANGULATION 33
2.6 ASSUMPTIONS FOR THE STUDY 34

3 EXECUTIVE SUMMARY 35
3.1 INTRODUCTION 35
3.2 CONCLUSION 38

4 PREMIUM INSIGHTS 39
4.1 GLOBAL ABLATION TECHNOLOGY MARKET OVERVIEW 39
4.2 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ABLATION TECHNOLOGY MARKET 39
4.3 GLOBAL ABLATION TECHNOLOGY MARKET, BY TYPE AND REGION 40
4.4 GLOBAL ABLATION TECHNOLOGY MARKET, BY APPLICATION 40
4.5 GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY PRODUCT 41

5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Emergence of next-generation ablation products and technologies 43
5.2.1.2 Rising incidence of cancer 43
5.2.1.3 Growing prevalence of cardiovascular diseases 44
5.2.1.4 Increasing number of ablation procedures 45
5.2.1.5 Increasing number of hospitals, surgical, and ablation centers 46
5.2.2 RESTRAINTS 46
5.2.2.1 Reuse and reprocessing of devices in developing countries 46
5.2.2.2 Healthcare cost-containment measures 47
5.2.2.3 Unfavorable regulatory scenario 47
5.2.3 OPPORTUNITIES 48
5.2.3.1 Growth Potential Offered by Emerging markets 48
5.2.3.2 Rising awareness related to ablation procedures 48
5.2.4 CHALLENGES 49
5.2.4.1 Product recalls 49
5.2.4.2 Therapeutic challenges 50

6 INDUSTRY TRENDS 51
6.1 KEY INDUSTRY TRENDS: ABLATION MARKET 51
6.1.1 INDUSTRY CONSOLIDATION 51
6.1.2 INCREASING FOCUS OF GLOBAL PLAYERS TOWARDS DEVELOPING NATIONS 52
6.1.3 INCREASING FUNDING FOR ABLATION PRODUCT DEVELOPMENT AND COMMERCIALIZATION 52
6.1.4 NOTABLE DEVELOPMENTS IN MICROWAVE ABLATION SEGMENT 53
6.1.5 HIGH FOCUS OF MARKET PLAYERS TOWARDS DEVELOPMENT OF ADVANCED RADIOFREQUENCY ABLATION DEVICES 53
6.2 REIMBURSEMENT SCENARIO (QUALITATIVE INSIGHTS) 54
6.3 SUPPLY CHAIN ANALYSIS 55
6.4 PORTER’S FIVE FORCES ANALYSIS 55
6.4.1 THREAT FROM NEW ENTRANTS 56
6.4.2 THREAT OF SUBSTITUTES 57
6.4.3 BARGAINING POWER OF SUPPLIERS 58
6.4.4 BARGAINING POWER OF BUYERS 58
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 59

7 GLOBAL ABLATION TECHNOLOGY MARKET, BY TYPE 60
7.1 INTRODUCTION 61
7.2 RADIOFREQUENCY ABLATION 63
7.3 LASER/LIGHT ABLATION 64
7.4 ULTRASOUND ABLATION 65
7.5 ELECTRICAL ABLATION 67
7.6 CRYOABLATION 68
7.7 MICROWAVE ABLATION 69
7.8 HYDROTHERMAL ABLATION 70

8 GLOBAL ABLATION TECHNOLOGY MARKET, BY PRODUCT 72
8.1 INTRODUCTION 73
8.2 RADIOFREQUENCY ABLATORS 74
8.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS 75
8.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS 76
8.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 77
8.3 LASER/LIGHT ABLATORS 78
8.3.1 EXCIMER LASER ABLATORS 79
8.3.2 COLD LASER ABLATORS 80
8.4 ULTRASOUND ABLATORS 80
8.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 81
8.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS 82
8.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS 83
8.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS 84
8.5 ELECTRICAL ABLATORS 85
8.5.1 ARGON PLASMA/BEAM COAGULATORS 86
8.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS 87
8.6 CRYOABLATION DEVICES 88
8.6.1 TISSUE CONTACT PROBES 89
8.6.2 TISSUE SPRAY PROBES 89
8.6.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES 90
8.7 MICROWAVE ABLATORS 90
8.7.1 MICROWAVE THERMOTHERAPY DEVICES 91
8.8 HYDROTHERMAL ABLATORS 92
8.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES 92

9 GLOBAL ABLATION TECHNOLOGY MARKET, BY APPLICATION 93
9.1 INTRODUCTION 94
9.2 CARDIOVASCULAR DISEASE 95
9.3 CANCER 96
9.3.1 LIVER CANCER 97
9.3.2 KIDNEY CANCER 97
9.3.3 PROSTATE CANCER 97
9.3.4 LUNG CANCER 97
9.3.5 BONE METASTASIS 97
9.3.6 BREAST CANCER 97
9.4 OPHTHALMOLOGY 98
9.5 PAIN MANAGEMENT 100
9.6 GYNECOLOGY 101
9.7 UROLOGY 103
9.8 ORTHOPEDICS 104
9.9 COSMETIC/ AESTHETIC SURGERY 106
9.10 OTHER TREATMENTS 108

10 GLOBAL ABLATION TECHNOLOGY MARKET, BY REGION 109
10.1 INTRODUCTION 110
10.2 NORTH AMERICA 111
10.2.1 U.S. 113
10.2.1.1 Significant volume of ablation procedures in the country 113
10.2.1.2 Remarkable adoption of advanced ablation technology as compared to conventional technologies 114
10.2.1.3 Availability of funding for development of novel ablation devices 114
10.2.2 CANADA 116
10.3 EUROPE 117
10.3.1 GERMANY 120
10.3.1.1 Rising focus of market players 120
10.3.1.2 Large number of ongoing clinical trials 121
10.3.1.3 Favorable healthcare reimbursement scenario 121
10.3.1.4 Growing incidence of cancer and cardiovascular diseases 121
10.3.2 FRANCE 122
10.3.2.1 Availability of funding for development of novel ablation devices in the country 122
10.3.2.2 Availability of training programs and reimbursement for certain products in France 123
10.3.3 U.K. 124
10.3.3.1 Large patient population base 124
10.3.3.2 Availability of research funding 125
10.3.3.3 Expanding presence of market players 125
10.3.3.4 Government recommendations encouraging adoption of ablation technology 126
10.3.4 REST OF EUROPE 126
10.3.4.1 Rapidly increasing aging population in the region 127
10.3.4.2 Increasing market penetration of leading ablation manufacturers in the region 127
10.3.4.3 Prominent adoption of ablation in Italy 127
10.4 ASIA-PACIFIC 129
10.4.1.1 Increasing government initiatives in the region 129
10.4.1.2 Awareness programs and conferences in APAC 129
10.4.1.3 Rising focus of market players 131
10.4.2 JAPAN 133
10.4.2.1 Well-developed healthcare system 133
10.4.2.2 Rising baby boomer population coupled with cancer incidence in the country 133
10.4.2.3 Rising government focus towards the development of the medical device industry 133
10.4.3 CHINA 134
10.4.3.1 High incidence of target diseases and rapidly aging population 135
10.4.4 INDIA 136
10.4.4.1 Remarkable patient base in the country 136
10.4.4.2 Improving Healthcare Infrastructure In The Country 136
10.4.4.3 Rising focus of global players 137
10.4.5 REST OF ASIA-PACIFIC 138
10.5 REST OF THE WORLD 139

11 COMPETITIVE LANDSCAPE 142
11.1 OVERVIEW 142
11.2 MARKET SHARE ANALYSIS 143
11.3 COMPETITIVE SITUATION AND TRENDS 144
11.3.1 NEW PRODUCT LAUNCHES & APPROVALS 145
11.3.2 MERGERS & ACQUISITIONS 146
11.3.3 GEOGRAPHICAL EXPANSIONS 146
11.3.4 AGREEMENTS AND JOINT VENTURES 148
11.3.5 OTHER DEVELOPMENTS 148

12 COMPANY PROFILES 150
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 150
12.2 MEDTRONIC PLC 151
12.3 BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON INC.) 157
12.4 ST. JUDE MEDICAL, INC. 160
12.5 BOSTON SCIENTIFIC CORPORATION 164
12.6 ANGIODYNAMICS, INC. 168
12.7 ATRICURE, INC. 171
12.8 CONMED CORPORATION 175
12.9 OLYMPUS CORPORATION 177
12.10 SMITH & NEPHEW 179
12.11 GALIL MEDICAL INC. (ACQUIRED BY BTG INTERNATIONAL LTD.) 181

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 184
13.1 INSIGHTS OF INDUSTRY EXPERTS 184
13.2 DISCUSSION GUIDE 185
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 190
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 192
13.5 AVAILABLE CUSTOMIZATIONS 194
13.6 RELATED REPORTS 195
13.7 AUTHOR DETAILS 196


LIST OF TABLES

TABLE 1 CLINICAL RESEARCH STATUS BY ABLATION TECHNOLOGIES AS OF 2017* 32
TABLE 2 MAJOR MERGER & ACQUISITION ACTIVITIES IN THE ABLATION TECHNOLOGY INDUSTRY (2013-2016) 51
TABLE 3 GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 62
TABLE 4 ABLATION TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 62
TABLE 5 RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 64
TABLE 6 LASER/LIGHT ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 65
TABLE 7 ULTRASOUND ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 66
TABLE 8 ELECTRICAL ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 67
TABLE 9 CRYOABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 69
TABLE 10 MICROWAVE ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 70
TABLE 11 HYDROTHERMAL ABLATION MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 71
TABLE 12 GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 74
TABLE 13 RADIOFREQUENCY ABLATORS MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 74
TABLE 14 RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 75
TABLE 15 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET SIZE,
BY REGION, 2014-2021 (USD MILLION) 76
TABLE 16 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 77
TABLE 17 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 78
TABLE 18 LASER/LIGHT ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 78
TABLE 19 LASER/LIGHT ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 79
TABLE 20 EXCIMER LASER ABLATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 79
TABLE 21 COLD LASER ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 80
TABLE 22 ULTRASOUND ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 80
TABLE 23 ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 81
TABLE 24 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 82
TABLE 25 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET SIZE,
BY REGION, 2014-2021 (USD MILLION) 83
TABLE 26 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET SIZE,
BY REGION, 2014-2021 (USD MILLION) 83
TABLE 27 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 84
TABLE 28 ELECTRICAL ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 85
TABLE 29 ELECTRICAL ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 85
TABLE 30 ARGON PLASMA/BEAM COAGULATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 86
TABLE 31 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 87
TABLE 32 CRYOABLATION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 88
TABLE 33 CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 88
TABLE 34 TISSUE CONTACT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 89
TABLE 35 TISSUE SPRAY PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 89
TABLE 36 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET SIZE,
BY REGION, 2014-2021 (USD MILLION) 90
TABLE 37 MICROWAVE ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 90
TABLE 38 HYDROTHERMAL ABLATORS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 92
TABLE 39 GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 94
TABLE 40 ABLATION TECHNOLOGY MARKET SIZE FOR CARDIOVASCULAR DISEASE,
BY REGION, 2014-2021 (USD MILLION) 96
TABLE 41 ABLATION TECHNOLOGY MARKET SIZE FOR CANCER, BY REGION,
2014-2021(USD MILLION) 97
TABLE 42 ABLATION TECHNOLOGY MARKET SIZE FOR OPHTHALMOLOGY TREATMENT,
BY REGION, 2014-2021 (USD MILLION) 99
TABLE 43 ABLATION TECHNOLOGY MARKET SIZE FOR PAIN MANAGEMENT,
BY REGION, 2014-2021 (USD MILLION) 101
TABLE 44 CURRENTLY APPROVED FDA ABLATION TECHNOLOGY PRODUCTS FOR GYNECOLOGICAL TREATMENT 102
TABLE 45 ABLATION TECHNOLOGY MARKET SIZE FOR GYNECOLOGY TREATMENT,
BY REGION, 2014-2021 (USD MILLION) 102
TABLE 46 ABLATION TECHNOLOGY MARKET SIZE FOR UROLOGY, BY REGION,
2014-2021(USD MILLION) 103
TABLE 47 ABLATION TECHNOLOGY MARKET SIZE FOR ORTHOPEDICS, BY REGION,
2014-2021 (USD MILLION) 106
TABLE 48 ABLATION TECHNOLOGY MARKET SIZE FOR COSMETIC/ AESTHETIC SURGERY,
BY REGION, 2014-2021 (USD MILLION) 107
TABLE 49 ABLATION TECHNOLOGY MARKET SIZE FOR OTHER TREATMENTS, BY REGION, 2014-2021 (USD MILLION) 108
TABLE 50 GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 110
TABLE 51 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 112
TABLE 52 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 112
TABLE 53 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 113
TABLE 54 U.S.: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 115
TABLE 55 CANADA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 117
TABLE 56 EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 119
TABLE 57 EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 119
TABLE 58 EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 120
TABLE 59 GERMANY: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 122
TABLE 60 FRANCE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 124
TABLE 61 U.K.: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 126
TABLE 62 REST OF EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 128
TABLE 63 ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 131
TABLE 64 ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 132
TABLE 65 ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 132
TABLE 66 JAPAN: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 134
TABLE 67 CHINA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 135
TABLE 68 INDIA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 137
TABLE 69 REST OF APAC: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 138
TABLE 70 ROW: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 140
TABLE 71 ROW: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 141
TABLE 72 TOP 5 NEW PRODUCT LAUNCHES & APPROVALS, 2012-2015 145
TABLE 73 MERGERS & ACQUISITIONS, 2013-2016 146
TABLE 74 GEOGRAPHICAL EXPANSIONS, 2014-2016 147
TABLE 75 TOP 3 AGREEMENTS AND JOINT VENTURES, 2013-2015 148
TABLE 76 TOP 5 OTHER DEVELOPMENTS, 2014-2016 148


LIST OF FIGURES

FIGURE 1 GLOBAL ABLATION TECHNOLOGY MARKET: RESEARCH METHODOLOGY STEPS 22
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
FIGURE 3 RESEARCH METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 4 RESEARCH METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 5 ESTIMATED NUMBER OF NEW CANCER CASES, BY 2020 (THOUSANDS) 29
FIGURE 6 POPULATION AGED 65 AND ABOVE, BY REGION (IN MILLION):
2015, 2030, AND 2050 30
FIGURE 7 CLINICAL RESEARCH STATUS IN THE ABLATION MARKET 2017* 31
FIGURE 8 NEW ABLATION PRODUCT LAUNCHES, 2013-2016 32
FIGURE 9 DATA TRIANGULATION METHODOLOGY 33
FIGURE 10 ABLATION TECHNOLOGY MARKET SIZE, BY TYPE (2016 VS. 2021) 36
FIGURE 11 ABLATION TECHNOLOGY MARKET SHARE, BY PRODUCT (2016 VS. 2021) 36
FIGURE 12 ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION (2016 VS. 2021) 37
FIGURE 13 ABLATION TECHNOLOGY MARKET SHARE, BY REGION (2016) 37
FIGURE 14 RISING INCIDENCES OF CANCER & CARDIAC DISEASES - PRIMARY DRIVER OF THE ABLATION TECHNOLOGY MARKET DURING THE FORECAST PERIOD 39
FIGURE 15 INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR ABLATION PRODUCT MANUFACTURERS DURING THE FORECAST PERIOD 39
FIGURE 16 U.S. COMMANDED THE LARGEST SHARE OF THE ABLATION TECHNOLOGY MARKET IN 2016 40
FIGURE 17 CARDIOVASCULAR DISEASE TREATMENT SEGMENT TO DOMINATE THE ABLATION TECHNOLOGY MARKET DURING THE FORECAST PERIOD 40
FIGURE 18 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 41
FIGURE 19 GLOBAL ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 20 GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020 44
FIGURE 21 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 55
FIGURE 22 MICROWAVE ABLATION SEGMENT TO GROW AT THE HIGHEST CAGR DURING 2016 TO 2021 61
FIGURE 23 MICROWAVE ABLATOR IS THE FASTEST-GROWING SEGMENT IN THE GLOBAL ABLATION TECHNOLOGY MARKET 73
FIGURE 24 CARDIOVASCULAR DISEASE TREATMENT ABLATION MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 94
FIGURE 25 NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES, BY COUNTRY: 2013 105
FIGURE 26 GLOBAL ABLATION TECHNOLOGY MARKET SHARE, BY COUNTRY (2016-2021) 110
FIGURE 27 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT 111
FIGURE 28 EUROPE: ABLATION TECHNOLOGY MARKET SNAPSHOT 118
FIGURE 29 ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT 130
FIGURE 30 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES & APPROVALS AS THEIR KEY GROWTH STRATEGY FROM 2013 TO 2016 142
FIGURE 31 GLOBAL ABLATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2015 143
FIGURE 32 NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY STRATEGY 144
FIGURE 33 GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS 150
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT 151
FIGURE 35 JOHNSON AND JOHNSON: COMPANY SNAPSHOT 157
FIGURE 36 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 160
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 164
FIGURE 38 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT 168
FIGURE 39 ATRICURE, INC.: COMPANY SNAPSHOT 171
FIGURE 40 CONMED CORPORATION: COMPANY SNAPSHOT 175
FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT 177
FIGURE 42 SMITH & NEPHEW: COMPANY SNAPSHOT 179
FIGURE 43 BTG INTERNATIONAL LTD. : COMPANY SNAPSHOT 181
 

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る